Last reviewed · How we verify

NCT07308951

Effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation on Quality of Life in Chronic Cancer Pain

Recruiting now NA Last updated 30 December 2025
What this trial tests

NA trial testing TEAS in Quality of Life in 290 participants. Currently enrolling.

Timeline
10 September 2025
Primary endpoint
31 October 2026
31 December 2026

Quick facts

Lead sponsorThe Third Affiliated hospital of Zhejiang Chinese Medical University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment290
Start date10 September 2025
Primary completion31 October 2026
Estimated completion31 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The Third Affiliated hospital of Zhejiang Chinese Medical University

Who can join

Adults 18 to 80, any sex, with Quality of Life or Chronic Cancer Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to objectively evaluate the effect of Patient-Controlled Transcutaneous Electrical Acupoint Stimulation (PC-TEAS) on improving the quality of life in patients with chronic cancer pain, thereby providing evidence-based medical support for its efficacy and offering practical basis for patients to achieve home-based auxiliary treatment based on their own needs. Furthermore, by observing and comparing changes in indicators such as pain-related scores, analgesic consumption, emotional scores, spontaneous bowel movements, and adverse events, this research will comprehensively assess the advantages of PC-TEAS in the management of chronic cancer pain and explore other potential benefits of this intervention for patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of TEAS

Trials testing the same drug.

Other recruiting trials for Quality of Life

Currently open trials in the same condition.

Other The Third Affiliated hospital of Zhejiang Chinese Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07308951.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing